SUMMARY Lymph node biopsy specimens from 22 patients with chronic inflammatory joint disease have been studied. The histology has been reviewed and immunoperoxidase staining carried out for the major immunoglobulin heavy and light chains, macrophage markers, and MT1, MB1 surface markers. Although two of these patients had been initially diagnosed and treated for malignant lymphoma, the clinical course has not substantiated the diagnosis, and on review malignancy could not be identified in any of the biopsy specimens. Careful attention to specific histological features, together with adequate clinical information, is therefore essential if the true nature of the lymph node enlargement is to be recognised. Clinical review of the 22 patients suggested that lymphadenopathy may, in some cases, be an early feature of inflammatory polyarthritis, and this was supported by the observation that 20% of patients with otherwise unexplained reactive lymphadenopathy developed an inflammatory polyarthropathy within one year of biopsy.
Lymph node enlargement often causes clinical concern, especially when it is associated with systemic symptoms such as weight loss, anaemia, and malaise. The anatomical site, e.g., supraclavicular fossa, may enhance the suspicion of malignancy. Although lymphadenopathy in association with chronic inflammatory joint disease is well described,1 2 there may be a strong indication for biopsy, especially if lymph node enlargement occurs before clinical, radiological, or serological stigmata of joint disease are present. These indications may be further strengthened by the described association between rheumatoid arthritis and malignant lymphoma. 226 Kelly, Malcolm, Griffiths follicular hyperplasia with large, sometimes irregular follicles but retention of the normal follicular architecture of the lymph node (Fig. 1 ). There were many mitoses, which were confined to the germinal centres, and there was a polymorphous cell population with tingible body macrophages within the centres. Interfollicular areas showed prominent vascularity with many plasma cells and only occasional mitotic figures (Fig. 2) . There was no compression of reticulin fibres within the node. All these latter features helped to separate a reactive follicular hyperplasia from a follicular lymphoma because in lymphoma the follicles have a more uniform population of cells, show mitoses in the interfollicular area in addition to those within the follicles, and plasma cells are scarce. 1 Robertson et al have shown the observed incidence of lymphadenopathy in rheumatoid patients to be significantly higher than that in a matched hospital control group.2 The increased incidence was almost entirely due to axillary lymphadenopathy. Therefore clinical concern remains regarding the aetiology of cervical and supraclavicular lymph node enlargement in patients with rheumatoid arthritis, and this is reflected in the fact that 59% of our patients had their biopsies for lymphadenopathy at these sites.
There is conflicting evidence about the association of rheumatoid arthritis and lymphoma. " It is important that the clinician appreciates the relation between lymphadenopathy and early joint disease, and it is clearly mandatory that the reporting pathologist is made aware of any coexistent rheumatic disease so that detailed attention to the histological features already noted may prevent a serious misdiagnosis of lymphoma.
